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Abstract
Backgound: Marginal zone B cells have been implicated in the production of autoantibodies in murine models of
lupus. It has been suggested that they contribute to lupus immunopathogenesis through their enhanced effector
functions and their repertoire that is biased toward autoreactive specificities. In the B6.NZM2410.Sle.Sle2.Sle3 (B6.TC)
model of lupus, the majority of marginal zone B cells are located outside the marginal zone and inside the follicles.
Genetic alterations of this strain have shown a correlation between autoimmune pathogenesis and the presence of
intrafollicular marginal zone B cells. This study was designed first to strengthen our original observations and to
determine how the marginal zone B cells from the lupus-prone mice respond to stimulations and interact with T cells.
Results: The intrafollicular location of B6.TC MZB cells starts before disease manifestations and puts MZB cells in
direct contact with CD4
+ T cells. Two different autoreactive B cell receptor (BCR) transgenic models showed that
the expression of the Sle susceptibility loci enhances the presence of MZB cells inside the follicles. In vitro, B6.TC
MZB cells were better effectors than B6 MZB cells with enhanced proliferation and antibody (Ab) production,
including anti-DNA Ab, in response to stimulation with TLR ligands, immune complexes or anti-CD40. Furthermore,
B6.TC MZB and CD4
+ T cells showed a reciprocally enhanced activation, which indicated that their contacts inside
B6.TC follicles have functional consequences that suggest an amplification loop between these two cell types.
Conclusions: These results showed that the NZM2410 susceptibility loci induce MZB cells to locate into the
follicles, and that this breach of follicular exclusion occurs early in the development of the autoimmune
pathogenesis. The enhanced responses to stimulation and increased effector functions of MZB cells from lupus-
prone mice as compare to non-autoimmune MZB cells provide a mechanism by which the failure of MZB cell
follicular exclusion contributes to the autoimmune process.
Background
Systemic lupus erythematosus (SLE) is an autoimmune
disease in which defects in multiple B cell subsets have
long been recognized [1]. Marginal zone (MZ) B cells
are enriched for autoreactive specificities through the
expression of self-reactive germline-encoded BCRs [2].
MZB cells transport antigen inside the follicles [3] and
are potent T-cell activators that respond more rapidly
than follicular (FO) B cells to T-dependent antigen [4].
MZB cells also differentiate rapidly into plasma cells
[5-9]. Finally, MZB cells respond better to T cells than
FOB cells in vitro but not in vivo [10], showing that
physiological barriers prevent in vivo activation of MZB
cells [11]. These observations have led to hypothesize
the existence of a tolerance checkpoint which maintains
follicular exclusion of MZB cells and retains them in the
MZ area where very few T cells are present. A related
checkpoint that efficiently censors the entrance of auto-
reactive cells in the IgM
+ CD27
+ Bc e l lc o m p a r t m e n t
(the human equivalent of murine MZB cells [12,13]),
has been identified [14]. The expansion of MZB cells
has been directly implicated in lupus pathogenesis in
some murine models [15-17], but not others [18,19].
However, their involvement through altered functions or
location has not yet been assessed.
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express the NZM2410-derived Sle1, Sle2 and Sle3 sus-
ceptibility loci [20], a large proportion of MZB cells are
located inside the follicles [21]. On the other hand,
NZM.TAN mice, a genetically related strain that does
not produce pathogenic antibodies (Abs), present an
expanded MZB cell compartment that remains in the
MZ location, and expresses the negative regulator CD5,
which correlates with lower activation and function [22].
Furthermore, B7-2 deficiency in B6.TC mice restores
MZB cell follicular exclusion concomitant with a signifi-
cant reduction in autoimmune pathology [21]. Overall,
these results strongly suggested that a breach in MZB
cell follicular exclusion plays a significant role in lupus
pathogenesis in the B6.TC model.
In this report, we show that a large proportion of B6.
TC MZB cells enter the follicles early in the disease pro-
cess, before autoAb are secreted, and these intrafollicu-
lar MZB cells establish contact with CD4
+ T cells. We
have used the anti-DNA 56R [23] and rheumatoid factor
(RF) AM14 [24] heavy chain (HC) BCR transgenic (Tg)
models, in which the Tg B cells are preferentially
selected to the MZ compartment ([23] and Morel,
unpublished). In both of these models, we showed that
the expression of Sle susceptibility loci favors the
recruitment of the Tg MZB cells to the follicles. In
vitro, B6.TC MZB cells proliferated more and produced
m o r eI g Mt h a nB 6M Z Bc e l l si nr e s p o n s et oT L R ,
immune complex (IC) and CD4
+ T cell stimulation.
Finally, B6.TC MZB cells activated CD4
+ Tc e l l sm o r e
than either B6 MZB cells or FOB cells. Overall, our
results demonstrate that autoreactive MZB cells have a
greater propensity for intrafollicular location, due at
least in part to their enhanced responsiveness to a vari-
ety of stimuli. Our results also suggest that B6.TC MZB
cells contribute to autoimmune pathogenesis through an
enhanced mutual relationship with CD4
+ T cells that
they encounter in the follicles.
Results
B6.TC MZB cells enter the follicles and interact with CD4
+
T cells
We have previously reported that over 80% of CD1d
hi
B220
+ cells are CD21
+ CD23
-,w h i c hi n d i c a t e st h a t
CD1d can be used to track MZB cells by immunofluror-
escence [21]. As for older mice, a large number of MZB
cells were present inside the follicles of 3 mo old B6.TC
mice (Figure 1A). Morphometric quantitation indicated
that CD1d
hi B220
+ cells accounted for about 50% of the
B cells in the follicles of 3 mo old B6.TC mice, and that
this number increased to about 75% in 10 mo old mice
(Figure 1B). Intrafollicular B6.TC MZB cells established
numerous contacts with CD4
+ Tc e l l s( F i g u r e1 C ) .O n
the contrary, the few B6 MZB cells present in the
follicles were very rarely in contact with CD4
+ T cells
(Figure 1C). CD4-MZB contacts clearly exist in 3 mo
old B6.TC mice, although not as extensively as in older
mice (data not shown). In addition to the MZB cell
intrafollicular location, the scattering of CD4
+ T cells
across the B6.TC follicles facilitates CD4-MZB contacts.
Overall, these results show that B6.TC MZB cells are
present inside the follicles in young mice, before auto-
immune manifestations are manifested [20], and that
they establish numerous contacts with CD4
+ T cells.
The expression of the Sle susceptibility loci increases the
intrafollicular location of MZB cells
To further evaluate whether the autoimmune suscept-
ibility loci carried by the B6.TC mice, we used two auto-
reactive B cell receptor HC Tg models that have been
widely used to study B cell tolerance mechanisms, 3H9/
56R and AM14 [25]. B cells carrying the DNA-specific
56R HCTg are preferentially recruited in the MZB com-
partment [23] and the expression of the Sle2 locus
expands the size of the 56R MZB compartment [26].
We used immunofluorescent staining of spleen sections
to determine whether this recruitment of these Tg B
cells to the MZ was associated with a breach of follicu-
lar exclusion. As expected, a large number of IgM
a Tg B
cells expressed the MZB marker CD1d in both B6.
Sle2.56R and B6.56R spleens (Figure 2A). The percen-
tage of CD1d
+ B cells inside the follicles was signifi-
cantly higher in B6.56R than in B6 (34.56 ± 4.71 vs. 2.5 ±
0.65%, p = 0.002; compare Figure 2A and 2C to
Figure 1A and 1B). However, CD1d
+ IgM
a cells were in
significantly higher numbers in the MZ than in the FO
areas in the B6.56R spleens (Figure 2C). In contrast, they
were in equivalent numbers in the MZ and FO areas of
the B6.Sle2.56R mice. This indicated that 56R MZB cells
locate to the follicles with a higher frequency than non-
Tg MZB cells, and that the Sle2 lupus susceptibility locus
further increases this migration.
When paired with endogenous V8, the AM14 HC Tg
encodes for anti-IgG2a
a IgM
a RF [24]. In B6.TC.AM14.
IgH
a/b and B6.AM14.IgH
a/b mice, the AM14 HC Tg B
cells differentiate in the presence of the AM14 cognate
antigen encoded by the endogenous IgG2a
a on either
the autoimmune B6.TC or the control B6 background.
In these mice, the great majority (> 90%) of IgM
a cells
express the AM14 HC Tg, but some IgM
a+ cells express
the endogenous IgH
a HC. However, there was no differ-
ence between IgH
b and IgH
a MZB cell distribution on
either non-Tg B6 or B6.TC background (data not
shown). This indicated that the endogenous non-trans-
genic B cells do not contribute to the results reported
below, and that the Tg B cells accounted for the differ-
ences in MZB cell distribution between non-Tg and
AM14 Tg mice. A large number of IgM
a cells expressed
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Page 2 of 13Figure 1 Intrafollicular location of MZB cells in B6.TC spleens. A. Representative spleen sections from 3 mo old B6.TC (left) and B6 (right)
mice stained with Moma-1-FITC, CD1d-PE and B220-PB. The B220
+ CD1d
+ MZB cells show as bright pink while the other B cells show as blue.
The ring of Moma-1
+ metallophillic macrophages delineates the MZ inner edge. B. Percentage of CD1d
+ B220
+ B cells relative to total B220
+ B
cells outside (MZ) and inside (FO) the Moma-1
+ ring in 3 mo and 10 mo old B6 and B6.TC mice. The data show means and standard errors of
the mean (SEM) calculated of 4 MZ and FO areas for each mouse. ***: p < 0.001 for t tests. C. Representative spleen sections from 10 mo old B6.
TC (left) and B6 (right) mice stained with CD4-FITC, CD1d-PE and B220-PB. Boxed areas show multiple contacts between green B6.TC CD4 T cells
and pink MZB cells, but not in the B6 spleen. Original magnification: 200X.
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Page 3 of 13Figure 2 Intrafollicular location of 56R and AM14 HC Tg MZB cells. Representative spleen sections of B6.Sle2.56R and B6.56R (A, 100X) and
B6.TC.AM14.IgH
a/b and B6.AM14.IgH
a/b (B, 200X) mice stained with Moma-1-FITC, CD1d-PE, and IgM
a-biotin-SA-PB.C .Quantitation in pixels
corresponding to the stain combination specific for each cell type of CD1d
+ IgM
a cells in the MZ (pink) and corresponding FO (blue) B cell areas
in B6.Sle2.56R, B6.56R, B6.TC.AM14.IgH
a/b and B6.AM14.IgH
a/b mice. Paired MZ and FO values within a strain were compared with the Wilcoxon
signed ranked test, and the B6.TC.AM14.IgH
a/b and B6.AM14.IgH
a/b MZ values were compared with the Mann-Whitney test. CD21
hi CD23
hi
representing the T2 and MZB precursor cells expressed as the percentage of transgenic IgM
a cells (D), and percentage of CD21
hi CD23
lo MZ B
cells expressed as the percentage of transgenic IgM
a cells (E) and their absolute numbers (F) in B6.Sle2.56R and B6.56R and B6.TC.AM14.IgH
a/b
and B6.AM14.IgH
a/b mice. Graphs show means and SEMs, and the statistical significance of Student t tests. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
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a/b and B6.AM14.IgH
a/b
spleens (Figure 2B), indicating again that these HC Tg B
cells were preferentially recruited to the MZB compart-
ment. As for B6.56R, the proportion of CD1d
+ IgM
a
MZB cells that breached follicular exclusion was greater
in B6.AM14.IgH
a/b than in B6 mice (30.50 ± 7.23 vs. 2.5 ±
0.6%, p = 0.007; compare Figure 2B and 2C to Figure 1A
and 1B). The Sle1-3 loci expressed in B6.TC mice signifi-
cantly increased the shift of CD1d
+ IgM
a MZB cells
toward the follicles, with a significantly higher proportion
of CD1d
+ IgM
a in the follicles than in the MZ in B6.TC.
AM14.IgH
a/b mice, but not in B6.AM14.IgH
a/b mice
(Figure 2B and 2C). In addition, there were significantly
more CD1d
+ IgM
a cells in the MZ of B6.AM14.IgH
a/b
than B6.TC.AM14.IgH
a/b mice (6649 + 2169 vs. 1232 +
597 pixels, respectively; p = 0.01), and the proportion of
CD1d
+ IgM
a cells with an intrafollicular location was sig-
nificantly higher in B6.TC.AM14.IgH
a/b than in B6.
AM14.IgH
a/b spleens (70.11 ± 4.14 vs. 30.50 ± 7.23%, p <
0.001). Overall these results show in two models that Tg
B cells expressing an autoreactive HC are not only pre-
ferentially selected to the MZB compartment, but they
are also more likely to breach follicular exclusion. More-
over, expression of the Sle susceptibility loci enhances
the migration of the HC Tg MZB cells into the follicles,
more strongly when the three loci are expressed than
with just Sle2.
We examined whether the intrafollicular location of
Tg B cells in the lupus-prone background correlated
with the size of the MZ B cell precursor or MZB cell
compartments. We have previously shown that B6.TC
mice have a markedly reduced MZB cell precursor sub-
set [22]. Here we showed that the percentage of trans-
genic IgM
a B cells in the CD23
hi CD21
hi subset, which
contains the precursors of the Tg MZB cells, was
reduced in both B6.Sle2.56R and B6.TC.AM14.IgH
a/b
mice as compared to their B6 controls (Figure 2D).
There was however no difference for the absolute
number of these cells between the lupus prone and B6
background for either transgene (0.87 +0 . 1 2v s .1 . 7 1+
0.53 × 10
6 cells for B6.Sle2.56R vs. B6.56R; 1.08 +0 . 2 5
vs. 0.93 +0 . 2 7×1 0
6 cells for B6.TC.AM14.IgH
a/b vs.
B6.AM14.IgH
a/b). The proportion and number of Tg
MZB cells was significantly higher in B6.Sle2.56R than
in B6.56R mice (Figure 2E and 2F), as previously
reported [26]. In the B6.TC.AM14.IgH
a/b mice, the pro-
portion Tg MZB cells was lower, but their absolute
number was significantly higher than in B6.AM14.IgH
a/b
mice (Figure 2E and 2F). These results suggest that the
selection of the B cells to the MZB subset, possibility
bypassing or staying for a shorter period of time in the
MZ B precursor compartment, and the size of the MZB
cell compartment may be involved in their propensity
for intra-follicular migration.
MZB cells migrate back and forth between the mar-
ginal and follicular zones transporting antigen to the fol-
licle through a process involving CXCL13 and S1P [27].
We have previously shown that B6.TC MZB cells
express higher levels of CXCR5, the CXCL13 receptor,
and that they migrate more in response to CXCL13 and
S1P than B6 MZB cells [21]. MZB cells from B6.TC
mice have in fact a significantly enhanced propensity to
migration even in the absence of any stimuli. About 1%
of splenic B cells from B6 and B6.TC mice migrated
through transwells in medium alone. A significantly
greater percentage of these splenic migrated cells were
MZBs in B6.TC than in B6 mice (Figure 3A), while no
difference was observed for FOBs (Figure 3B). Since B6.
TC mice have more MZB cells than B6, the compared
the ratios of spontaneously migrated MZB cells to the
initial MZB cell input, and obtained a significant differ-
ence between B6.TC and B6 mice (Figure 3C). On the
contrary, the ratio of spontaneously migrated FOB cells
over the FOB cell input was equivalent between the two
strains (Figure 3D). This indicated that B6.TC MZB
cells have an increased propensity for migration, which
is likely to disrupt their steady state balance between the
marginal and follicular zones.
B6.TC MZB cells proliferate more than B6 MZB cells
We compared the proliferation of sorted B6 and B6.TC
FOB and MZB cells in response to a range of stimuli in
3 d cultures. Overall, B6.TC B cells proliferated more
Figure 3 Spontaneous migration of B6 or B6.TC B cells in
transwell assays in the absence of stimulation. Percentage of
migrated cells that presented a MZB (IgM
+ CD23
- CD21
hi)
phenotype (A) or a FOB (IgM
+ CD23
+ CD21
int) phenotype (B). C.
Ratios of the percentage of spontaneously migrated MZB cells over
the percentage of MZBs in input B cells D. Ratios of the percentage
of spontaneously migrated FOB cells over the percentage of FOBs
in input B cells. Graphs show means and SEMs, and the statistical
significance of Student t tests. *: p < 0.05.
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FOB cells, leading to the greatest proliferation in B6.TC
MZB cells (Figure 4). More specifically, B6.TC MZB
cells proliferated more than B6 MZB cells in response
to LPS (Figure 4A) and CpG (data not shown). Among
the four types of B cells tested, only B6.TC MZB cells
proliferated to anti-chromatin ICs (Figure 4B), and B6.
TC MZB cells proliferated the most to non-autoreactive
protein ICs, with the lowest response observed in B6
FOB (Figure 4C). Finally, FOB cells responded poorly to
anti-CD40 as compared to MZB cells, and among these,
B6.TC MZB cells proliferated significantly more than B6
MZB cells to this stimulation (Figure 4D).
As for the non-cellular stimuli evaluated in Figure 4A-D,
PMA and ionomycin-activated B6 CD4
+ T cells induced a
titrated proliferative response in which B6.TC MZB cells
responded more than B6 MZB cells (Figure 4E). B6.TC
CD4
+ T cells induced a similarly high proliferation in both
B6 and B6.TC MZB cells. The PMA and ionomycin stimu-
lation induced a higher level of CD154 expression B6.TC
than in B6 CD4
+ T cells (Figure 4F), which suggested that
the difference between B6 and B6.TC MZB response
c o u l db eo v e r c o m eb yav e r ys t r o n gs t i m u l a t i o n .I n
support of this hypothesis, only LPS still induced a signifi-
cantly higher proliferation in B6.TC than B6 MZB cells in
5 d cultures (data not shown). Overall, these results
showed that B6.TC MZB cells proliferated more than B6
MZB cells in response to TLR ligands, IC or CD4
+ Tc e l l
stimulation.
B6.TC MZB cells secrete more IgM in response to multiple
stimuli, including CD4
+ T cells
B6.TC MZB cells, but not FOB cells, spontaneously
secreted more IgM than B6 MZB cells (p < 0.01,
Table 1). For this reason, we compared IgM secretion
between MZB and FOB cells from both strains with
absolute values (Table 1), as well as fold induction by
each stimulus over the no-stimulation controls. B6.TC
MZB cells secreted higher amounts of IgM than B6
MZB cells in response to LPS, CpG, chromatin or pro-
tein ICs, or anti-CD40 (Figure 5A-E and Table 1). It
should be noted that B6.TC MZB cells were highly
responsive to ICs as compared to the three other types
of B cells (Figure 5C and 5D). As observed for
B6 FO
TC FO
TC MZ
B6 MZ
AD BC
E F
Figure 4 Proliferative response of FOB or MZB cells from B6 or B6.TC mice. Proliferation after 3 d in culture with LPS (A), chromatin ICs (B),
protein ICs (C), anti-CD40 (D), or activated CD4 T cells (E). Proliferation was assessed by CFSE dilution as the percentage of B220
+ cells in the last
two cell division cycles (CSFE-low). Means and SEM, Student t test comparisons: *: p < 0.05; **: p < 0.01, ***: p < 0.001. For A-D, representative
histograms indicating the CFSE-low gate for B220-gated cells are shown for each stimulatory condition, with filled gray histograms
corresponding to B6 FOB, thin black lines to B6.TC FOB, gray lines to B6 MZB and thick black lines to B6.TC MZB cells. F. Representative
histogram showing surface CD154 expression on B6.TC (black) and B6 (gray) CD4
+ T cells without (dotted lines) or with PMA/ionomycin
stimulation (solid lines). CD154 median fluorescence intensity (MFI) is indicated for activated cells gated by the horizontal markers.
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Page 6 of 13proliferation (Figure 4F), the production of IgM
increased as the result of the strain of origin of both B
and CD4
+ T cells, and the type MZ or FO of B cells.
This resulted in the highest increase in IgM production
(over 3.5 fold on average) provided by B6.TC T cells
stimulating B6.TC MZB cells (Figure 5F).
Anti-DNA Abs were not produced by any type of B
cells in absence of stimulation (Table 1). Both LPS and
anti-CD40 induced a significantly higher production of
anti-ssDNA IgM in B6.TC MZB cells than in B6 MZB
cells (Figure 5G-H). Finally, anti-dsDNA IgM was pro-
duced in higher amounts in MZB cells than in FOB
cells stimulated with LPS, regardless of the strain of ori-
gin (Figure 5I). Anti-CD40 induced only a small amount
of anti-dsDNA IgM, and there was a trend for higher
production by B6.TC MZB cells (data not shown). The
other stimulatory conditions failed to induce anti-DNA
IgM above control (data not shown). These data demon-
strate that B6.TC MZB cells secrete higher amounts of
Abs, including autoAbs, in response to TLR ligation, IC
or CD4
+ T cell stimulation.
Both LPS-stimulated B6.TC MZB and FOB cells
expressed significantly more CD138, a plasma cell mar-
ker, than the B6 B cell equivalent (Figure 6A and 6G).
In contrast, only MZB cells expressed CD138 in
response to anti-CD40, and the response from B6.TC
MZB cells was about 2 folds higher than that of B6
MZB cells (Figure 6B and 6G). Finally, CD4
+ T cells
induced a greater CD138 expression in MZB than in
FOB cells, but there was no difference between B6 and
B6.TC (Figure 6C). As for B cell proliferation, this dis-
crepancy between stimulation with anti-CD40 and CD4
+
T cells maybe due to the low level of CD154 expression
by CD4
+ T cells from young mice. CXCR5 expression is
one of the determinants of MZB cell migration to the
follicles [3]. As previously reported [21], CXCR5 expres-
sion was higher on B6.TC than B6 MZB cells (Figure
6D and 6G). Interestingly, B6.TC CD4
+ T cells induced
a higher CXCR5 expression than B6 CD4
+ T cells in all
four groups of B cells (Figure 6E), suggesting that CD4
+
T cells may contribute to CXCR5 expression on B6.TC
MZB cells. Finally, B6.TC MZB cells responded signifi-
cantly more than B6 MZB cells to either B6 or B6.TC
CD4
+ T cells by expressing early activation marker
CD69, with again the combination of B6.TC MZB and
CD4
+ T cells resulting in the highest CD69 expression
on B cells (Figure 6F).
B6.TC MZB cells induce a greater proliferation and
activation in CD4
+ T cells
MZB cells are better activators of CD4
+ T cells than
FOB B cells [4]. To test whether B6.TC MZB cells were
better activators of CD4
+ T cells than B6 MZB cells, we
analyzed T cells responses in criss-cross co-cultures in
which the MZB cells were either of B6 or B6.TC origin.
FOB cells were used as controls. We also addressed
whether the B6 or B6.TC origin of CD4
+ T cells
impacted their response to MZB cells. We have shown
that B6.TC CD4
+ T cells are more activated than B6
CD4
+ T cells [28], which was confirmed in these in
vitro e x p e r i m e n t s( F i g u r e7 B ,D ,E ) .B 6C D 4
+ T cells
proliferated more in response to B6.TC MZB cells than
B6 MZB cells, or to FOB cells from either strain (Figure
7A). Moreover, B6.TC CD4
+ T cells proliferated more
in response to B6.TC MZB cells than B6 MZB cells.
Both MZB and FOB cells from B6.TC origin resulted in
a greater CD4
+ T cell size than B6 B cells (Figure 7B).
The greater T and B cell proliferation corresponded to a
reduction of the percentage of CD4
+ T cells in the co-
cultures (Figure 7C), which could correspond to either
activation-induced cell death or to an outgrowth of the
B cells. Regarding T cell activation, only B6.TC MZB
cells induced a significantly increased CD69 expression
(Figure 7D). Moreover, MZB cells significantly decreased
CD62L expression on B6 CD4
+ T cells, and this
decrease was enhanced with MZB cells from B6.TC ori-
gin (Figure 7E). CD62L expression on B6.TC CD4
+ T
cells was not changed by co-culture with B cells, except
with B6 FOB, which surprisingly increased CD62L
(Figure 7E). Overall, these results showed that B6.TC
MZB cells are more potent activators of CD4
+ Tc e l l s
than B6 MZB cells, and that different patterns of
Table 1 Ab production from B6 and B6.TC FOB and MZB
cells in response to various stimuli in 5 d cultures
B6 FO TC FO B6 MZ TC MZ
mean SD mean SD mean SD mean SD
total IgM
control 0.09 0.02 0.10 0.01 0.08 0.01 0.12** 0.01
LPS 0.57 0.02 0.67 0.09 0.68 0.17 1.31*** 0.06
CpG 0.26 0.03 0.59** 0.01 0.57 0.01 0.79* 0.05
protein ICs 0.08 0.00 0.21** 0.03 0.11 0.01 0.63*** 0.01
chromatin ICs 0.16 0.01 0.21 0.00 0.15 0.12 0.37* 0.01
anti-CD40 0.11 0.03 0.11 0.04 0.32 0.02 0.95*** 0.08
B6 CD4 0.19 0.02 0.19 0.03 0.22 0.05 0.24 0.01
TC CD4 0.31 0.05 0.30 0.02 0.35 0.03 0.37 0.04
ssDNA IgM
control 0.05 0.00 0.07 0.02 0.06 0.01 0.06 0.01
LPS 0.40 0.09 0.55* 0.01 0.70 0.04 0.79 0.07
anti-CD40 0.06 0.01 0.06 0.01 0.10 0.03 0.25** 0.07
dsDNA IgM
control 0.05 0.00 0.06 0.01 0.05 0.00 0.06 0.00
LPS 0.17 0.06 0.20 0.04 0.33 0.04 0.35 0.08
Mean ODs and standard deviations (SD) of ELISA assays performed on
supernatants diluted 1:10 from one representative experiment.
* indicates the level of significance of t tests between B6 and B6.TC FOB cells
on the left or between B6 and B6.TC MZB cells on the right. *: p < 0.05; **: p
< 0.01, ***: p < 0.001.
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tion of the T cells themselves.
Discussion
MZB cells constitute potent effector cells that can read-
ily differentiate into plasma cells [8] and activate naïve
CD4
+ T cells [4]. Moreover, MZB cells are enriched in
autoreactive specificities and an enlargement of the
MZB compartment has been implicated in murine lupus
[15-17,29] and type 1 diabetes [30,31]. These results
suggested that a controlled size of the MZB cell com-
partment and its sequestration within the MZ are
important to maintain immune tolerance. Our own
results in the NZM2410 model supported this hypoth-
esis by showing an inverse correlation between the
amount of B cells physically present in the MZ and
autoimmune pathology [21,22]. In this study, we report
that the breach of MZB cell follicular exclusion occurs
early in B6.TC spleens, indicating that it is not a conse-
quence of the progressive disorganization of the follicles
associated with the lymphoid expansion and plasma cell
accumulation in this strain [32]. It also indicates that
the intrafollicular MZB cells have the opportunity to
contribute to the early events in the disease process. We
also demonstrated the existence of direct contacts
between B6.TC MZB cells and CD4
+ T cells inside the
Figure 5 Antibody production of FOB or MZB cells from B6 or B6.TC mice. Total IgM (A-F), anti-ssDNA (G-H) and dsDNA IgM (I) production
in supernatants from 5 d cultures with LPS (A, G, I), CpG (B), protein ICs (C), chromatin ICs (D), anti-CD40 (E, H), and B6 or B6.TC CD4
+ T cells (F).
Results are expressed as fold increase over the IgM production by the corresponding B cell type and strain in the absence of any stimulation.
Results are representative of two independent assays with 3 mice per strain in each. Means and SEM, Student t test comparisons: *: p < 0.05; **:
p < 0.01, ***: p < 0.001.
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opportunity to activate each other.
The two models of autoreactive HC Tg B cells that we
used, 56R and AM14, are directed against prototypic
lupus antigens, DNA [23] and IgG2a
a-chromatin ICs
[33]. As previously reported for 56R B cells [23], the
AM14 HC Tg B cells were preferentially recruited to
the MZB compartment, reflecting their enrichment for
autoimmune specificities. More importantly, both 56R
and AM14 MZB cells were in significantly greater num-
bers inside the follicles than WT MZB cells. The
expression of Sle2 locus alone for 56R, and more
strongly of Sle1-3 for AM14 increased the shift of 56R
and AM14 MZB cells towards the follicles. These results
are in full support of our hypothesis that autoreactive
MZB cells have a greater propensity for intrafollicular
location, based on the specificity of their BCR and the
expression of Sle susceptibility loci. The greater migra-
tory behavior of B6.TC MZB cells either spontaneously
(this study) or in response to CXCL13 or S1P [21] may
contribute at least in part to their increased intrafollicu-
lar location. Further studies will be necessary to
Figure 6 Induction of effector cell surface markers in FOB or MZB cells from B6 or B6.TC mice.C D 1 3 8( A-C), CXCR5 (D-E), and CD69
(F) induction in 5 d cultures with the indicated stimulatory conditions, including CD4
+ T cells from B6 or B6.TC origin. Results are representative
of two independent assays. Student t test comparisons, or Dunnett’s Multiple Comparison Tests when multiple groups were compared: *: p <
0.05; **: p < 0.01, ***: p < 0.001. J. G. Representative histograms showing CD138 and CXCR5 staining. Filled gray histograms: B6 FOB, thin black
lines: B6.TC FOB, gray lines: B6 MZB and thick black lines: B6.TC MZB cells.
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follicule.
Our in vitro experiments have confirmed established
results: First, B6.TC B cells have greater effector func-
tions than B6 B cells [20,34], and second, MZB cells
respond more than FOB cells to TLR ligands [35,36] or
to T cells [7,10], and are better activators of CD4
+ T
cells [4]. Most importantly, our experiments demon-
strated that the greater responsiveness of MZB cells is
enhanced in lupus-prone B6.TC mice, making the B6.
TC MZB cells a very potent effector population. In addi-
tion to TLR ligands, B6.TC MZB cells responded
strongly to IC stimulation. The defective NZW allele of
FcgRIIb [37] may contribute to this phenotype, although
down-regulation of FcgRIIb
NZW on MZB cells has not
been reported, in general and in the B6.TC strain
(Morel, unpublished). The strong response of B6.TC
MZB cells to chromatin ICs strongly suggest that these
cells are enriched for anti-chromatin autoreactive speci-
ficities. Loss of tolerance to chromatin represents a criti-
cal step in the initiation of systemic autoimmunity in
lupus [38,39], and it is likely that B6.TC MZB cells
contribute to the autoimmune process though their
reactivity to chromatin. Our results also showed a
mutual activation between B6.TC MZB cells on B6 CD4
+ T cells, indicating that these MZB cells have the
potential to activate non-autoreactive T cells. The stron-
gest responses were however observed between B6.TC
MZB and B6.TC CD4
+ T cells, which are likely to share
autoreactive specificities, such as chromatin [28]. This
suggests an amplification mechanism between B6.TC
MZB and CD4
+ T cells in which MZB cells respond
aberrantly to TLR or IC stimulation, secrete autoAb and
move inside the follicles where they encounter CD4
+ T
cells. Upon these encounters, the CD4
+ T cells become
activated themselves and can in turn provide further
activation signals to MZB cells or other cell types to
participate in the autoimmune process.
Conclusions
This study showed that the NZM2410 susceptibility loci
induce MZB cells to locate into the follicles, and that
this breach of follicular exclusion occurs early in the
development of the autoimmune pathogenesis. The
Figure 7 CD4
+ T cell proliferation and activation in response to FOB or MZB cells from B6 or B6.TC mice. A. Proliferation in 5 d cultures.
B. Forward scatter mean fluorescence intensity (mfi). C. Percentage of CD4
+ T cells. CD69 (D) and CD62L (E) expression. All cells were gated on live
CD4
+ T cells. Proliferation was assessed with CFSE dilution as the percentage of CD4
+ T cells in the last two cell division cycles (CSFE-low). Results
are representative of two independent assays. Means and SEM and Dunnett’s Multiple Comparison Tests. *: p < 0.05; **: p < 0.01, ***: p < 0.001.
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tor functions of MZB cells from lupus-prone mice as
compare to non-autoimmune MZB cells provide a
mechanism by which the failure of MZB cell follicular
exclusion contributes to the autoimmune process. Over-
all, our results suggest a novel tolerance checkpoint in
regulating systemic tolerance consisting of containing
h y p e r a c t i v eM Z Bc e l l si nt h em a r g i n a lz o n ea w a yf r o m
T cells.
Methods
Mice
The triple congenic B6.NZM2410.Sle.Sle2.Sle3 (BcN/
LmoJ in JAX
® Mice, referred to as B6.TC) [20] and
C57BL/6J (B6) mice were maintained at University of
Florida. B6.Sle2.56R and B6.56R breeders were a gener-
o u sg i f tf r o mC h a n d r aM o h a n( U T S W ) .B 6 . T C . A M 1 4 .
IgH
a/b and B6.AM14.IgH
a/b were obtained by breeding
B6.TC and B6 to B6.AM14.lpr, which carry the AM14
heavy chain (HC) transgene (Tg) (kindly provided by
Mark Shlomchik, Yale Medical School) and C57BL/6J-
Cg-IghaThy1aGpila/J (B6
a)m i c e .T h ep r e s e n c eo ft h e
IgH
a allele was screened by flow cytometry with allo-
type-specific anti-IgM
a ( I g h 6 a ) .T h ep r e s e n c eo ft h e
AM14 HC Tg was detected by PCR as previously
described [24]. All in vitro experiments used 2 to 3 mo
old females before any manifestation of clinical disease.
All animal protocols were approved by the Institutional
Animal Care and Use Committee of the University of
Florida.
Histology
Immunofluorescence staining was performed on frozen
sections as previously described [22], with Moma-1-
FITC (Serotec) or CD4-FITC (GK1.5), CD1d-PE (1B1),
and IgM
a-Biotin-SA-PB or B220-PB (RA3-6B2). Quanti-
tation was performed with a MetaMorph 7.5 image ana-
lysis station, which quantifies the number of pixels for a
given color corresponding to a specific stain combina-
tion. For each B6.TC and B6 mice, the numbers of
CD1d
+ B220
+ cells and CD1d
- B220
+ were computed in
four areas with homogeneous staining selected on each
side of the Moma-1
+ ring on 100X or 200X amplifica-
tion images. Five mice were evaluated for each strain
and age group.
Cell cultures
B220
+ CD23
- CD21
hi MZB and B220
+ CD23
+ CD21
int
FOB cells were purified on a FACSAria cell sorter, yield-
ing 95-98% purity in both strains. We used the anti-
CD21 7E9 Ab which binds equally the B6 and NZW
alleles of CD21 [40]. CD4
+ T cells were enriched by
negative selection with magnetic beads (Myltenei).
CFSE-labeled MZB or FOB cells (10
5 per well) were cul-
tured with or without CFSE-labeled CD4
+ T cells in
RPMI 1640 containing 10% FCS for either 3 or 5 d with
LPS (Sigma, 5 ug/ml), ODN1826 CpG (InvivoGen, 1 ug/
ml), anti-CD40 (R&D Systems, 10 ug/ml), anti-chroma-
tin or protein ICs (50 ug/ml final Ab concentration).
ICs were prepared as previously described [41]. Briefly,
chromatin-enriched 0.2 μM filtered supernatant (12.5%
of total well volume) from B6.TC spleen cells cultured
for 48 h, or TNP-BSA (12.5 ug/ml, Biosearch Technolo-
gies) were incubated with the PL2-3 IgG2a anti-chroma-
tin Ab or with anti-TNP IgG2a (BD pharmingen),
respectively, for 30 min before the assay. In some cul-
tures, CD4
+ T cells (1×10
6/ml) were pre-activated over-
night with 1 μg/ml of PMA and 1 μM ionomycin. In
each assay, 2-3 mice per strain were used and each
result reported in this study is representative of at least
2 independent assays. Culture supernatants were assayed
at 1:10 dilution for total IgM, anti-ssDNA and anti-
dsDNA IgM by ELISA carried out as previously
described [42]. Spontaneous migration of MZB and FOB
cells was measured intranswell assays as previously
described [21] with an initial input of 2 × 10
6 negatively
selected total splenic B cells.
Flow cytometry
The following conjugated mAbs were used: CD23
(B3B4), CD1d (1B1), CD21 (7E9), CD69 (H1.2 F3),
CD62L (MEL14), CD138 (281-2), B220 (RA3-6B2), IgM
(II/41), CXCR5 (2G8), all, except 7E9, purchased from
BD Pharmingen. Stained cells were analyzed on FACS-
Calibur cytometer (BD Biosciences). Dead cells were
excluded based on forward and side scatters
characteristics.
Statistical analysis
Data were analyzed with the GraphPad Prism 4.0 soft-
ware package with the appropriate tests as indicated in
the text.
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